Home > Insider Trading > Filing (0001209191-19-052936)

Filing Details

Accession Number:: 0001209191-19-052936
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-10 17:03:14
Reporting Period:: 2019-10-08

Accepted Time:: 2019-10-10 17:03:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660334	Verrica Pharmaceuticals Inc.	VRCA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	200 Garrett Street, Suite S Charlottesville VA 22902		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-08	5,208	$14.02	8,063,716	No	4	P	Direct
Common Stock	Acquisiton	2019-10-09	8,778	$14.06	8,072,494	No	4	P	Direct
Common Stock	Acquisiton	2019-10-10	6,900	$15.05	8,079,394	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,307,219	Indirect	See Footnote
Common Stock	256,634	Indirect	See Footnote

Footnotes

The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $13.98 to $14.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Consists of 7,754,783 shares of common stock held by Mr. Manning and 308,933 shares of common stock held by Mr. Manning jointly with his spouse.
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $13.90 to $14.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Consists of 7,754,783 shares of common stock held by Mr. Manning and 317,711 shares of common stock held by Mr. Manning jointly with his spouse.
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $14.74 to $15.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Consists of 7,754,783 shares of common stock held by Mr. Manning and 324,611 shares of common stock held by Mr. Manning jointly with his spouse.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB.
The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.